Representing Billev Pharma East Ltd., Katja Pečjak Reven and Maša Voler attended CPHI Frankfurt 2025, held from 28–30 October 2025 in Frankfurt, Germany.
An essential gathering in the pharma world
CPHI Frankfurt is the leading global event for the pharmaceutical industry. This year’s edition brought together thousands of professionals and over 2,000 exhibiting companies, all converging to explore innovation, regulation, and market access in pharma.
New zones and content tracks at the event expanded on themes such as AI, digital transformation, sustainable manufacturing and next‑generation biologics.
Our presence – purpose and priorities
At Billev Pharma East we see events like CPHI as more than mere exhibitions. Katja and Maša used the opportunity to:
- deepen their insight into emerging trends across regulation, supply chains and manufacturing,
- reinforce relationships with existing partners who rely on our regulatory expertise,
- engage with new contacts and open possibilities for collaboration that align with our commitment to excellence and market access.
In today’s fast‑evolving pharmaceutical landscape, knowledge and connections matter as much as credentials.
Why this matters for Billev Pharma East
Participating in CPHI Frankfurt 2025 affirms our role as a forward‑looking service partner in the European pharma ecosystem. By being present where ideas, regulation and industry strategy converge, we reinforce our ability to support clients facing complex regulatory pathways, supply chain challenges, or digital‑health transformations.
Looking ahead
The conversations, insights and networks activated in Frankfurt will continue to fuel our momentum. As the industry transitions toward smarter manufacturing, greater sustainability and deeper digitalisation, Billev Pharma East remains ready to lead and support. We look forward to building on the energy from CPHI Frankfurt and harnessing it for new opportunities.